AzTrials
AzTrials

Caries,DentalPhase 2/3NCT04147091

Nano-hydroxyapatite and Ozone - Effect on Approximal Initial Caries

A Phase 2/3 study testing ApaCare & Repair in people with Caries,Dental, run by Pomeranian Medical University Szczecin.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objectives: to assess the efficiency of three methods of enamel remineralization on initial approximal caries: 1. a nano-hydroxyapatite gel, 2. gaseous ozone therapy 3. combination of a nano-hydroxyapatite gel and ozone. Read more about this study

Who is it for?
Ages 20 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Caries,Dental
What is being tested?
ApaCare & Repair
Could I receive a placebo?
No, everyone receives an active treatment
How many people
92 participants
Where
No sites listed yet
Study dates
Feb 2012to Dec 2016
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • -initial approximal enamel lesions on premolar and molar teeth

Who cannot join

  • distal surface of the last tooth in arch, overlapping teeth
  • fillings on approximal surfaces of teeth of interest
  • ongoing orthodontic therapy with braces or other appliances

About this study

Official title: Influence of Nano-hydroxyapatite and Ozone on Approximal Initial Caries

Objectives: to assess the efficiency of three methods of enamel remineralization on initial approximal caries: 1. a nano-hydroxyapatite gel, 2. gaseous ozone therapy 3. combination of a nano-hydroxyapatite gel and ozone.

Materials and Methods: Patients (n=92, age 20-30y) with initial approximal enamel lesions on premolar and molar teeth (n=546) randomly allocated to three groups subjected to a 6-months treatment: Group I: domestic nano-hydroxyapatite remineralizing gel, group II: in-office ozone therapy, group III: both remineralizing gel and ozone therapy. Caries lesions assessed on bitewing radiographs at baseline, after 1 year and after 2 years.

Conditions
Caries,Dental
Being tested
ApaCare & Repair
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ApaCare & RepairOther

    Also called OzonyTron

    Initial cariuos lesions were treated.

Study groups in NCT04147091
Study groupRoleWhat they receive
domestic nanohydroxyapatite gel ApaCare & RepairExperimental6-months treatment, caries lesions were assessed on bitewing radiographs at baseline, after 1 year and after 2 years
Receives: Other: ApaCare & Repair
in-office ozone therapy OzonyTronExperimental6-months treatment, caries lesions were assessed on bitewing radiographs at baseline, after 1 year and after 2 years
Receives: Other: ApaCare & Repair
both remineralizing gel and ozone therapyExperimental6-months treatment, caries lesions were assessed on bitewing radiographs at baseline, after 1 year and after 2 years
Receives: Other: ApaCare & Repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Remineralizing effect

    Caries lesions were assessed on bitewing radiographs

    Measured: baseline

Secondary outcomes (1)
  1. Remineralizing effect - follow-up

    Caries lesions were assessed on bitewing radiographs

    Measured: after 1 year and after 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2019
  2. Study startFeb 2012
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
92 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04147091
Sponsor's protocol ID
KB-0012/102/11
Status last verified
Oct 2019
First submitted
21 Oct 2019
Last updated
31 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing ApaCare & Repair in people with Caries,Dental, run by Pomeranian Medical University Szczecin.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Remineralizing effect (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in